Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 14;61(12):2102-2114.
doi: 10.1515/cclm-2023-0571. Print 2023 Nov 27.

Toolkit for emerging technologies in laboratory medicine

Affiliations
Free article

Toolkit for emerging technologies in laboratory medicine

Ronda Greaves et al. Clin Chem Lab Med. .
Free article

Abstract

An emerging technology (ET) for laboratory medicine can be defined as an analytical method (including biomarkers) or device (software, applications, and algorithms) that by its stage of development, translation into broad routine clinical practice, or geographical adoption and implementation has the potential to add value to clinical diagnostics. Considering the laboratory medicine-specific definition, this document examines eight key tools, encompassing clinical, analytical, operational, and financial aspects, used throughout the life cycle of ET implementation. The tools provide a systematic approach starting with identifying the unmet need or identifying opportunities for improvement (Tool 1), forecasting (Tool 2), technology readiness assessment (Tool 3), health technology assessment (Tool 4), organizational impact map (Tool 5), change management (Tool 6), total pathway to method evaluation checklist (Tool 7), and green procurement (Tool 8). Whilst there are differences in clinical priorities between different settings, the use of this set of tools will help support the overall quality and sustainability of the emerging technology implementation.

Keywords: change management; emerging technology (ies); health technology assessment; laboratory medicine; technology readiness level; unmet clinical need.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Coronavirus (COVID-19) update: FDA authorizes first COVID-19 test for self-testing at home [press release] . U.S. Food and Drug Administration; 17th Nov 2020. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19... .
    1. Coronavirus (COVID-19) update: FDA authorizes antigen test as first over-the-counter fully at-home diagnostic test for COVID-19 [press release] . FDA; December 15, 2020. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19... .
    1. FDA . In vitro diagnostics EUAs – antigen diagnostic tests for SARS-CoV-2 U.S. food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-em... .
    1. FDA . In vitro diagnostics EUAs – molecular diagnostic tests for SARS-CoV-2: U.S. food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-em... .
    1. FDA . In vitro diagnostics EUAs – serology and other adaptive immune response tests for SARS-CoV-2: U.S. Food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-em... .

MeSH terms

LinkOut - more resources